Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective
Vishal Kumar, Satyabrata Kundu, Arti Singh, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 1, pp. 158-178
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Mitochondria: It is all about energy
Amaloha Casanova, Anne Wevers, Santiago Navarro‐Ledesma, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 94
Targeting histone deacetylases for cancer therapy: Trends and challenges
Liang Tao, Fengli Wang, Reham M. Elhassan, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 6, pp. 2425-2463
Open Access | Times Cited: 78
The interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing
Yuqing Liu, Yejun Tan, Zheyu Zhang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 26
YY1 Lactylation Aggravates Autoimmune Uveitis by Enhancing Microglial Functions via Inflammatory Genes
Jiaxing Huang, Xiaotang Wang, Na Li, et al.
Advanced Science (2024) Vol. 11, Iss. 19
Open Access | Times Cited: 24
Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer’s disease
Nicha Puangmalai, Urmi Sengupta, Nemil Bhatt, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 4, pp. 101766-101766
Open Access | Times Cited: 44
SIRT1/SREBPs-mediated regulation of lipid metabolism
Shan Shen, Mingyang Shen, Lirun Kuang, et al.
Pharmacological Research (2023) Vol. 199, pp. 107037-107037
Open Access | Times Cited: 35
Design, synthesis and biological evaluation of novel histone deacetylase (HDAC) inhibitors derived from β -elemene scaffold
Yuan Gao, Ji‐Long Duan, Xiawen Dang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 34
Fecal microbiota transplantation and short‐chain fatty acids protected against cognitive dysfunction in a rat model of chronic cerebral hypoperfusion
Shao‐Hua Su, Ming Chen, Yi‐Fang Wu, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. S1, pp. 98-114
Open Access | Times Cited: 30
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 620-620
Open Access | Times Cited: 14
Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives
Jingjing Pu, Ting Liu, Xuzhen Wang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
Tian‐Yu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116569-116569
Closed Access | Times Cited: 11
Role of histone deacetylases and their inhibitors in neurological diseases
Liying Zhang, Sen-Yu Zhang, Ri Wen, et al.
Pharmacological Research (2024), pp. 107410-107410
Open Access | Times Cited: 11
The role of short-chain fatty acids in central nervous system diseases: A bibliometric and visualized analysis with future directions
Ziwei Lan, Xiangqi Tang, Ming Lu, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26377-e26377
Open Access | Times Cited: 8
Effects of sleep deprivation on anxiety-depressive-like behavior and neuroinflammation
Dandan Cao, Yi Zhao, Yuting Wang, et al.
Brain Research (2024) Vol. 1836, pp. 148916-148916
Closed Access | Times Cited: 8
Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents
Márcia S. Pereira, Maria Teresa Cruz, Ana Fortuna, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104052-104052
Open Access | Times Cited: 8
Mechanism of Sirtuin1-Mediated Deacetylation of p65-Mediated Ferroptosis of Hippocampal Neurons in Cerebral Injury after Cardiopulmonary Resuscitation in Rats
Xiaoli Min, Ying Shi, Ying Xu, et al.
Neurochemical Research (2025) Vol. 50, Iss. 1
Closed Access | Times Cited: 1
Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression
Spandana Rajendra Kopalli, Tapan Behl, Ashishkumar Kyada, et al.
Neuroscience (2025) Vol. 569, pp. 161-183
Closed Access | Times Cited: 1
Elucidating the Beneficial Effects of Ginger (Zingiber officinale Roscoe) in Parkinson’s Disease
Efthalia Angelopoulou, Yam Nath Paudel, Sokratis G. Papageorgiou, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 10, pp. 838-848
Open Access | Times Cited: 28
α-Synuclein and Mechanisms of Epigenetic Regulation
Andrei Surguchov
Brain Sciences (2023) Vol. 13, Iss. 1, pp. 150-150
Open Access | Times Cited: 21
Targeting epigenetics: A novel promise for Alzheimer’s disease treatment
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2023) Vol. 90, pp. 102003-102003
Closed Access | Times Cited: 17
Why Is Longevity Still a Scientific Mystery? Sirtuins—Past, Present and Future
Patrycja Ziętara, Marta Dziewięcka, Maria Augustyniak
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 728-728
Open Access | Times Cited: 26
Selective Targeting of Class I HDAC Reduces Microglial Inflammation in the Entorhinal Cortex of Young APP/PS1 Mice
Chunyang Wang, Di Shen, Yingqiu Hu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4805-4805
Open Access | Times Cited: 15
Histone deacetylase (HDACs) inhibitors: Clinical applications
Kumar D. Shanmukha, Harikrishnareddy Paluvai, Santosh K. Lomada, et al.
Progress in molecular biology and translational science (2023), pp. 119-152
Closed Access | Times Cited: 14
Perspectives and new aspects of histone deacetylase inhibitors in the therapy of CNS diseases
Bo Han, Mengfei Wang, Jiayi Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115613-115613
Closed Access | Times Cited: 14
An updated patent review of histone deacetylase (HDAC) inhibitors in cancer (2020 – present)
Yimin Liu, Jing‐Ping Liou
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 5, pp. 349-369
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top